Evidence map›Paper›PMID 23729815›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Suspended microfluidics.

Benjamin P Casavant, Erwin Berthier, Ashleigh B Theberge, Jean Berthier, Sara I Montanez-Sauri, Lauren L Bischel, Kenneth Brakke, Curtis J Hedman, Wade Bushman, Nancy P Keller and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 183 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Suspended Tissue Engineering with Assemblable Microfluidics (STEAM).bioRxiv : the preprint server for biology · 2025
    Article
  6. Suspended Tissue Open Microfluidic Patterning (STOMP).Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  7. Article
  8. Suspended Tissue Open Microfluidic Patterning (STOMP).bioRxiv : the preprint server for biology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. On the Dynamic Contact Angle of Capillary-Driven Microflows in Open Channels.Langmuir : the ACS journal of surfaces and colloids · 2024
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Open millifluidics based on powder-encased channels.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  19. Article
  20. Interfacial tension driven open droplet microfluidics.Advanced materials interfaces · 2023
    Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Benjamin P CasavantCarbone Cancer Center, Madison, WI 53705, USA.
Erwin Berthier
Ashleigh B Theberge
Jean Berthier
Sara I Montanez-Sauri
Lauren L Bischel
Kenneth Brakke
Curtis J Hedman
Wade Bushman
Nancy P Keller
David J Beebe
University of Wisconsin Carbone Cancer Center · USBipar · FRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRSusquehanna University · USUniversity of Wisconsin–Madison · US

Funding

WNPRC Supplemental Request for Nonhuman Primate Enclosures to Equip HIV/AIDS-Related Research FacilitiesP51OD011106 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI Dorota A. Grejner-Brzezinska · 2012 to 2026
$150.7M
UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI AMY TRENTHAM-DIETZ · 1985 to 2026
$142.6M
ZOLEDRONATE PREVENTS BONE LOSS IN OVARIECTOMIZED RHESUS MONKEYSP51RR000167 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 1985 to 2011
$106.7M
Institutional Clinical and Translational Science AwardUL1TR000427 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2012 to 2016
$32.2M
INSTITUTIONAL CTSA (UW-MADISON): CLINICAL TRIALSUL1RR025011 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2007 to 2011
$29.5M
BIOTECHNOLOGY TRAINING PROGRAMT32GM008349 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI FOX, BRIAN G · 1989 to 2019
$22.5M
Molecular & Environmental Toxicology Pre-& Postdoctoral Training ProgramT32ES007015 · NIEHS · UNIVERSITY OF WISCONSIN-MADISON · PI CHRISTOPHER A BRADFIELD · 1985 to 2026
$11.5M
RESEARCH TRAINING IN HEMATOLOGYT32HL007899 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI Jane Ellen Churpek · 1998 to 2026
$8.2M
Understanding cell migration through microscale in vitro modelsR01EB010039 · NIBIB · UNIVERSITY OF WISCONSIN-MADISON · PI BEEBE, DAVID J, HUTTENLOCHER, ANNA · 2011 to 2014
$1.7M
Microchannel cell-based assays to enable cancer researchR33CA137673 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI BEEBE, DAVID J · 2009 to 2011
$1.4M
PULMONARY PATHOGEN DEFENSE MECHANISMST32HL007889 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI BOOM, HENRY · 1998 to 2007
$1.1M
NCATS NIH HHS UL1 TR000427NCI NIH HHS P30 CA014520NCI NIH HHS R33 CA137673NCRR NIH HHS 1UL1RR025011NCRR NIH HHS P51 RR000167NCRR NIH HHS UL1 RR025011NHLBI NIH HHS T32 HL007889NHLBI NIH HHS T32HL007889NHLBI NIH HHS T32 HL007899NIBIB NIH HHS R01 EB010039NIEHS NIH HHS T32 ES007015NIEHS NIH HHS T32ES007015NIGMS NIH HHS T32 GM008349NIGMS NIH HHS T32GM08349NIH HHS P51 OD011106NIH HHS P51OD011106/P51RR000167
6 · The paper itself

Abstract

Although the field of microfluidics has made significant progress in bringing new tools to address biological questions, the accessibility and adoption of microfluidics within the life sciences are still limited. Open microfluidic systems have the potential to lower the barriers to adoption, but the absence of robust design rules has hindered their use. Here, we present an open microfluidic platform, suspended microfluidics, that uses surface tension to fill and maintain a fluid in microscale structures devoid of a ceiling and floor. We developed a simple and ubiquitous model predicting fluid flow in suspended microfluidic systems and show that it encompasses many known capillary phenomena. Suspended microfluidics was used to create arrays of collagen membranes, mico Dots (μDots), in a horizontal plane separating two fluidic chambers, demonstrating a transwell platform able to discern collective or individual cellular invasion. Further, we demonstrated that μDots can also be used as a simple multiplexed 3D cellular growth platform. Using the μDot array, we probed the combined effects of soluble factors and matrix components, finding that laminin mitigates the growth suppression properties of the matrix metalloproteinase inhibitor GM6001. Based on the same fluidic principles, we created a suspended microfluidic metabolite extraction platform using a multilayer biphasic system that leverages the accessibility of open microchannels to retrieve steroids and other metabolites readily from cell culture. Suspended microfluidics brings the high degree of fluidic control and unique functionality of closed microfluidics into the highly accessible and robust platform of open microfluidics.

Indexed as

Microfluidic Analytical TechniquesModels, BiologicalAdrenal CortexBreast NeoplasmsCapillariesCell BiologyCell Line, TumorCell MembraneCell MovementCollagen Type IComputer SimulationFemaleHumansHydrocortisoneMaleMatrix Metalloproteinase InhibitorsCollagen Type IHydrocortisoneMatrix Metalloproteinase InhibitorsSteroidsarrayed migration platformhigh throughput metabolomicsmultiplexed cell culturepassive biphasic systemsspontaneous capillary flow

Identifiers

PMID23729815
PMCPMC3690848
OpenAlexW2576196423

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.